RET and familial medullary thyroid carcinoma: Activating point alterations represent another significant oncogenic mutation associated with inherited diseases such as multiple endocrine neoplasia 2A (MEN2A), multiple endocrine neoplasia 2B (MEN2B), and familial medullary thyroid carcinomas.